Neurotoxic action of kainic acid (Q40135643)

17 September 2017

1 reference

title

Neurotoxic action of kainic acid (English)

1 reference

17 September 2017

1 reference

Coyle JT

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 July 1983

1 reference

Journal of Neurochemistry

17 September 2017

published in

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

1-11

1 reference

Ventricular enlargement in schizophrenia: definition and prevalence

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

21 January 2018

Methylation Hypothesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Altered states of consciousness induced by N,N-dimethyltryptamine (DMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Central dopamine turnover in schizophrenic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Dopamine-sensitive adenylyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

The activities of brain dopamine-?-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Is schizophrenia an infectious disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Blood tryptophan metabolism in chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Brain catecholamines in schizophrenia -- a good case for noradrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Behavioural changes induced by N,N-dimethyl-tryptamine in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Brain tryptophan metabolism in schizophrenia: A post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Plasma prolactin concentrations and psychopathology in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Increased brain dopamine and dopamine receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Increased dopamine-receptor sensitivity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Change in the characteristics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: Effects of buffer washing of membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Phenylethylamine in paranoid chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Cerebral ventricular size in twins discordant for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Neuroendocrine Effects of Apomorphine: Characterization of Response Patterns and Application to Schizophrenia Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Human platelet monoamine oxidase activity in health and disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Increased synthesis of striatal dopamine by N,N-dimethyltryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Neuropathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Lack of enhancement of dimethyltryptamine formation in rat brain and rabbit lung in vivo by methionine or S-adenosylmethionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

The viral hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Possible virus in schizophrenia and some neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Neurochemical investigations of the interaction of N,N-dimethyltryptamine with the dopaminergic system in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

A twin study on three enzymes (DBH, COMT, MAO) of catecholamine metabolism. Correlations with MMPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

Twin Studies and Substrate Differences in Platelet Monoamine Oxidase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1983.TB11808.X

10.1111/J.1471-4159.1983.TB11808.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference